TickerKhojComparison · NSE · data 2026-11-02
Orchid Pharma Limited vs Sun Pharma Advanced Research Co. Ltd.
In plain words
Size: Sun Pharma Advanced Research Co. Ltd. is about 1.2 times the market value of Orchid Pharma Limited.
Valuation (P/E): Orchid Pharma Limited 485.7 vs Sun Pharma Advanced Research Co. Ltd. 3.6.
Return on equity: Sun Pharma Advanced Research Co. Ltd. 276.9% vs Orchid Pharma Limited 0.7%.
Debt to equity: Sun Pharma Advanced Research Co. Ltd. 0.42 vs Orchid Pharma Limited 0.2.
Differences in the numbers, not a recommendation of either stock.
Side by side
| ORCHPHARMA | SPARC | |
|---|---|---|
| Price | ₹830 | ₹176.05 |
| Market cap | ₹4,989 cr | ₹5,741 cr |
| P/E | 485.7 | 3.6 |
| P/B | — | — |
| ROE | 0.7% | 276.9% |
| ROCE | 0.2% | 232.1% |
| Debt / equity | 0.2 | 0.42 |
| Operating margin | 0.3% | 84.2% |
| Dividend yield | 0.00% | 0.00% |
| Sales growth, 3 years (yearly) | 22.7% | 98.9% |
| Profit growth, 3 years (yearly) | -40.1% | — |
| 1-year return | 16.1% | 29.4% |
| Revenue, last 12 months | ₹943 cr | ₹1,909 cr |
| Net profit, last 12 months | ₹9 cr | ₹1,584 cr |
| Latest quarter | Jun 2026 | Jun 2026 |
| Quarter net profit | ₹3 cr | ₹-21 cr |
| Quarter profit vs a year earlier | -78.4% | — |
| Promoter holding | 74.45% | 65.67% |
| Health check | Weak (3.4/10) | Strong (8.7/10) |
Common questions
Which has a higher P/E, Orchid Pharma Limited or Sun Pharma Advanced Research Co. Ltd.?
Orchid Pharma Limited trades at the higher P/E (485.7 against 3.6). A higher P/E means the market pays more for each rupee of past earnings; on its own it does not say which is better.
Which earns a higher return on equity?
Sun Pharma Advanced Research Co. Ltd. (276.9% against 0.7%).
Which carries more debt?
Sun Pharma Advanced Research Co. Ltd. has the higher debt-to-equity ratio (0.42 against 0.2).